newsfilter
← Latest News
GlobeNewswire·

Cartesian Therapeutics Announces New Employment Inducement Grant

  • Cartesian Therapeutics, Inc. granted an inducement award to a new employee on November 2, 2026.
  • The award consists of an option to purchase 50,000 shares of common stock at an exercise price of $6.34.
  • The grant was approved by the board of directors under the Amended and Restated 2018 Employment Inducement Incentive Award Plan.
  • The option vests 25% on November 2, 2027, with the remaining balance vesting in 36 equal monthly installments until full vesting on November 2, 2030.
  • The option carries a ten-year term \& was granted under Nasdaq Rule 5635(c)(4) as material to the employee's entry into employment.